Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
The global sepsis diagnostics market, valued at USD 835.40 million in 2023, is projected to reach USD 1.39 billion by 2029, driven by advancements in healthcare infrastructure and awareness of sepsis, ...
Co-Diagnostics (CODX) announced the development of a proprietary sample preparation instrument designed to streamline and simplify the workflow ...
Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle ...
A British COVID-19 test known as DnaNudge that gives results in just over an hour and which requires no laboratory was accurate in almost all cases, an academic review in the Lancet has found.
Overview of Platelet Aggregation Devices MarketThe global Platelet Aggregation Devices Market is valued at USD 590.65 Million in 2024 and is projected to reach a value of USD 1086 Million by 2035 at a ...
A simple blood test could reveal kidney disease earlier so more can be done to halt progression, while also allowing better ...
Stockhead on MSN
Lumos Diagnostics partners with WellStreet Urgent Care to advance FebriDx testing in US
Special Report: Lumos Diagnostics has inked an agreement with WellStreet Urgent Care to expand the use of its FebriDx rapid ...
The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and Human Services said on ...
Early detection is the key to protecting dogs from the serious effects of heartworm,” said Andrew Brown, CEO of Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results